Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 396

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 4
Chunk 396
---
18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
    2002

    32.2**
     
    Certification
    of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
    2002

    101.INS*
     
    Inline
    XBRL Instance Document

    101.SCH*
     
    Inline
    XBRL Taxonomy Extension Schema Document

    101.CAL*
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase Document

    101.DEF*
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase Document

    101.LAB*
     
    Inline
    XBRL Taxonomy Extension Labels Linkbase Document

    101.PRE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase Document

    104
     
    Cover
    Page Interactive Data File-the cover page interactive data is embedded within the Inline XBRL document or included within the Exhibit
    101 attachments.

*Filed
                                            herewith.

**Furnished
                                            herewith.

+Schedules
                                            and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any
                                            omitted schedule and/or exhibit will be furnished to the SEC upon request.

†Certain
                                            portions of this document that constitute confidential information have been redacted pursuant
                                            to Item 601(b)(10) of Regulation S-K.

    ^
    Indicates management contract or compensatory plan or arrangement.

47

SIGNATURES

In
accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

    CERO THERAPEUTICS
    HOLDINGS, INC.

    Date: August 22, 2025
    By:
    /s/
    Chris Ehrlich

    Name: 
    Chris Ehrlich

    Title:
    Chairman and Chief Executive Officer

    (Principal Executive Officer)

    Date August 22, 2025
    By:
    /s/
    Andrew Kucharchuk

    Name:
    Andrew Kucharchuk

    Title:
    Chief Financial Officer

    (Principal Financial and
    Accounting Officer)